Page last updated: 2024-09-05

sb 203580 and luteolin-7-glucoside

sb 203580 has been researched along with luteolin-7-glucoside in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(luteolin-7-glucoside)
Trials
(luteolin-7-glucoside)
Recent Studies (post-2010) (luteolin-7-glucoside)
3,48941,1372410152

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)luteolin-7-glucoside (IC50)
Mitogen-activated protein kinase 10Homo sapiens (human)2.45
Mitogen-activated protein kinase 14Homo sapiens (human)2.45

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bhutani, KK; Garg, D; Kadam, RU; Paul, AT; Roy, N1
Chen, MK; Chuang, YC; Hsieh, MJ; Lin, CC; Lin, JT; Lo, YS; Mahalakshmi, B; Velmurugan, BK1

Other Studies

2 other study(ies) available for sb 203580 and luteolin-7-glucoside

ArticleYear
Evaluation of proinflammatory cytokine pathway inhibitors for p38 MAPK inhibitory potential.
    Journal of medicinal chemistry, 2007, Dec-13, Volume: 50, Issue:25

    Topics: Anti-Inflammatory Agents; Biflavonoids; Cytokines; Flavanones; Flavones; Flavonoids; Glucosides; Hydrogen Bonding; Imidazoles; Luteolin; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Pyridines; Structure-Activity Relationship

2007
Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway.
    Biomolecules, 2020, 03-26, Volume: 10, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Flavones; Glucosides; Humans; Imidazoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines

2020